Style de citation APA (7e éd.)

X, J., S, Z., X, L., L, L., X, C., E, P., . . . M, L. (2021). Favorable Response to Olaparib in a Patient with Cancer of Unknown Primary Carrying a Germline BRCA1 R71K Mutation. Dove Medical Press.

Style de citation Chicago (17e éd.)

X, Jia, et al. Favorable Response to Olaparib in a Patient with Cancer of Unknown Primary Carrying a Germline BRCA1 R71K Mutation. Dove Medical Press, 2021.

Style de citation MLA (8e éd.)

X, Jia, et al. Favorable Response to Olaparib in a Patient with Cancer of Unknown Primary Carrying a Germline BRCA1 R71K Mutation. Dove Medical Press, 2021.